Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research Center
01. Februar 2024 08:15 ET
|
Clearmind Medicine Inc.
The licensing agreement refers to the company's dedicated treatment for cocaine addiction which previously indicated a significant decrease in cocaine craving Tel Aviv, Israel / Vancouver,...
Clearmind Medicine Achieved Positive Results in Cocaine Addiction Treatment
05. Dezember 2023 08:47 ET
|
Clearmind Medicine Inc.
Tel Aviv, Israel / Vancouver, Canada, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the "company"), a biotech company focused on...
Opioid and Stimulant Overdose Reporting Program to Expand Under Increased Federal Funding
17. Oktober 2023 12:45 ET
|
American College of Medical Toxicology
Phoenix, AZ, Oct. 17, 2023 (GLOBE NEWSWIRE) -- In September of 2022, the FDA awarded the American College of Medical Toxicology’s (ACMT) Toxicology Investigators Consortium (ToxIC) a 5-year $7.9...
Lightlake Therapeutics Inc. Announces Collaboration With NIDA and the Perelman School of Medicine at the University of Pennsylvania
23. Dezember 2015 09:00 ET
|
Opiant Pharmaceuticals, Inc.
NEW YORK, Dec. 23, 2015 (GLOBE NEWSWIRE) -- Lightlake Therapeutics Inc. (“Lightlake”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use,...
Born an Addict: ARUP Searches for Clues in the Umbilical Cord
28. April 2015 14:20 ET
|
ARUP Laboratories
SALT LAKE CITY, April 28, 2015 (GLOBE NEWSWIRE) -- Every baby born that enters this world, arrives with an umbilical cord in tow. For those babies born addicted to drugs, that umbilical cord is now a...
Designer Drugs Finally Detectable With Specialty Test From Norchem
19. Mai 2011 08:15 ET
|
Norchem
FLAGSTAFF, AZ--(Marketwire - May 19, 2011) - A new wave of designer drugs, technically legal because they are labeled "not for human consumption," are no less dangerous than their predecessors,...